Michael Bigham, Chairman and CEO at Paratek Pharmaceuticals, Inc. (PRTK), sold 12,600 shares at $8.96 ($113K) on 2018-10-15, disclosed to the SEC on 2018-10-16.
Open-market sale of $113k PRTK by Chairman and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.96 | 6,300 | $56K | 50.0% |
| 2 | $8.96 | 6,300 | $56K | 50.0% |
| Total | $8.96 avg | 12,600 | $113K | 100% |
| Filing → |
| PRTK | SELL | 2022-12-14 | $164K | — | Filing → |
| PRTK | SELL | 2022-11-01 | $21K | — | Filing → |
| PRTK | SELL | 2022-08-10 | $152K | — | Filing → |